BIOMARKER:

KRAS Q61H

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

KRAS Q61H	Hepatocellular Cancer	KRAS Q61H	Hepatocellular Cancer	sorafenib + BAY86-9766 Sensitive: C3 – Early Trials sorafenib + BAY86-9766 Sensitive : C3	sorafenib + BAY86-9766 Sensitive: C3 – Early Trials sorafenib + BAY86-9766 Sensitive : C3
KRAS Q61H	Colorectal Cancer	KRAS Q61H	Colorectal Cancer	trametinib + panitumumab Resistant: C3 – Early Trials trametinib + panitumumab Resistant : C3	trametinib + panitumumab Resistant: C3 – Early Trials trametinib + panitumumab Resistant : C3
KRAS Q61H	Sarcoma	KRAS Q61H	Sarcoma	trametinib Sensitive: C4 – Case Studies trametinib Sensitive : C4	trametinib Sensitive: C4 – Case Studies trametinib Sensitive : C4
KRAS Q61H	Colorectal Cancer	KRAS Q61H	Colorectal Cancer	cetuximab Resistant: D – Preclinical cetuximab Resistant : D	cetuximab Resistant: D – Preclinical cetuximab Resistant : D
KRAS Q61H	Non Small Cell Lung Cancer	KRAS Q61H	Non Small Cell Lung Cancer	P1446A-05 Sensitive: D – Preclinical P1446A-05 Sensitive : D	P1446A-05 Sensitive: D – Preclinical P1446A-05 Sensitive : D